Clinicians can bill Category 1 CPT Code 75580 for adjunctive use of the artificial intelligence (AI)-powered Cleerly Ischemia software for fractional flow reserve estimates based on coronary computed tomography angiography (CCTA) scans.
A new Category 1 CPT code may enhance reimbursement for the use of adjunctive artificial intelligence (AI)-enabled software to ascertain fractional flow reserve (FFR) estimates in cases of suspected coronary artery disease (CAD).
The Cleerly Ischemia software (Cleerly), which can now be billed with the Category 1 CPT code 75580, allows non-invasive lesion mapping for findings of CAD, according to Cleerly, the develop of the Cleerly Ischemia software.
Adjunctive use of the Cleerly Ischemia (Cleerly) software for CCTA-based fractional flow reserve estimates can now be billed with the new Category I CPT code 75580. (Image courtesy of Cleerly.)
“The Cleerly Ischemia software provides noninvasive estimates of FFR values that help healthcare professionals make critical decisions in the management of patients with suspected coronary artery disease,” noted James P. Earls, M.D, the chief medical officer of Cleerly. “Cleerly Ischemia was purposely designed to output estimates of FFR values that are guideline-recommended by professional societies, and to allow comprehensive mapping of both anatomic and physiologic data for each and every coronary lesion across the entire vascular tree.”
Cleerly noted the new Category 1 CPT code is an addition to previously established Category III CPT codes for billing of the company’s advanced coronary atherosclerosis analysis.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 4th 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
August 4th 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 4th 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.